+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Immunity Booster Supplement Market by Form, Ingredient Type, Distribution Channel, Product Type, Gender - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5181420
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immunity Booster Supplement Market grew from USD 11.57 billion in 2024 to USD 12.74 billion in 2025. It is expected to continue growing at a CAGR of 10.04%, reaching USD 20.55 billion by 2030.

Setting the Stage for Immunity Booster Supplement Market Dynamics

The global immunity booster supplement sector has evolved into a dynamic ecosystem shaped by shifting consumer behaviors, regulatory developments, and technological advancements. Heightened awareness of wellness and preventive healthcare has propelled demand for formulations designed to support immune functions. This report offers an authoritative exploration of market drivers, obstacles, and opportunities, providing decision-makers with a clear understanding of current dynamics.

In this introduction, we outline the critical factors influencing the trajectory of immunity supplements, from ingredient innovation to channel convergence. By examining the interplay between scientific research, consumer preferences, and policy frameworks, readers will gain a holistic perspective that sets the stage for deeper analysis in subsequent sections.

Emerging Dynamics Redefining the Immunity Booster Sector

Recent years have witnessed transformative shifts that have redefined the contours of the immunity booster category. Consumers are no longer satisfied with one-size-fits-all solutions; instead, they are gravitating toward personalized formulations that address unique health goals. Digital wellness platforms and telehealth consultations have become integral in shaping purchase decisions, providing data-driven insights that guide product development.

Moreover, sustainability considerations are compelling manufacturers to adopt transparent sourcing and eco-friendly packaging. Advances in biotechnology have enabled the extraction of potent bioactives from novel botanical sources, while breakthroughs in delivery systems enhance bioavailability. Together, these trends signal a paradigm shift toward holistic, science-backed wellness solutions that extend beyond traditional supplementation.

Assessing the Influence of 2025 US Tariffs on Market Flows

The introduction of United States tariffs in early 2025 has exerted multifaceted pressure on the global supply chain for immunity booster supplements. Increased import duties on raw materials, manufacturing equipment, and finished products have led to higher cost structures for many brands. Producers have responded by recalibrating procurement strategies, exploring alternative sourcing in regions with more favorable trade agreements to mitigate margin erosion.

Price sensitivity among end users has intensified, prompting some market participants to absorb a portion of additional costs to maintain competitive retail pricing. At the same time, luxury and premium segments have sustained their growth trajectory, as discerning consumers prioritize efficacy and ingredient transparency over minor price fluctuations. The net effect is a realignment of supply networks and a renewed emphasis on domestic manufacturing capabilities.

Nuanced Segmentation Reveals Diverse Paths to Growth

A granular view of market segmentation illuminates distinct growth trajectories across product categories. When analyzing by form, products ranging from effervescent and gummy to liquid and powder formulations, along with softgels and traditional tablet and capsule options, exhibit varied adoption patterns tied to convenience and consumer preference.

Ingredient-centric segmentation underscores that consumers seeking natural wellness solutions are embracing herbal extracts and multivitamin complexes, while those focused on targeted immune support increasingly turn to probiotics, pure vitamin C and zinc supplements. Distribution channels weave a complex tapestry where direct sales models coexist with robust e-commerce platforms, and brick-and-mortar outlets such as pharmacies, retail stores and specialty nutrition shops continue to capture significant share.

In terms of product type, the delineation between herbal, natural and synthetic offerings reveals consumer segments driven by perceptions of purity, scientific validation and cost considerations. Gender-oriented analysis highlights nuanced behavioral differences between female and male consumers in terms of flavor preferences, dosage forms and brand loyalty, informing tailored marketing strategies.

Regional Nuances Chart Distinct Opportunities for Advancement

Regional dynamics play a pivotal role in shaping the competitive landscape and investment priorities for immunity booster supplements. In the Americas, rising health-consciousness combined with mature retail infrastructure drives strong demand for premium, clinically validated products. The region’s regulatory environment favors transparent labeling and stringent quality standards, fostering consumer trust.

Europe, Middle East & Africa present a heterogeneous mix of established markets and emerging economies, each with unique distribution frameworks and cultural attitudes toward natural health solutions. Regulatory harmonization across the European Union facilitates cross-border trade, while markets in the Middle East and Africa are gaining traction through collaborations with international manufacturers.

Asia-Pacific stands out for its deep-rooted tradition of herbal medicine supplemented by rapid urbanization and digitalization. Local consumer affinities for botanical extracts and multivitamin complexes are complemented by expanding e-commerce ecosystems, creating an environment ripe for innovation and new product launches.

Competitive Landscape Highlights Strategic Moves by Leading Players

Key players in the immunity booster segment are deploying multifaceted strategies to fortify their market positions. Established supplement manufacturers are investing heavily in R&D collaborations with academic institutions to validate novel bioactive compounds, while agile startups are differentiating through innovative delivery systems such as nano‐encapsulation and sustained-release formulations.

Strategic alliances and licensing agreements are accelerating the integration of proprietary botanical extracts into mainstream supplement lines. Meanwhile, companies are honing digital engagement via personalized nutrition platforms that leverage consumer data to recommend tailored regimens. Mergers and acquisitions continue to consolidate market share, as acquisition targets with specialized ingredient portfolios or regionally entrenched distribution networks become prime candidates for expansion.

Strategic Imperatives for Industry Leaders to Excel

Leaders in the immunity booster domain should prioritize the establishment of data-driven consumer insights platforms that integrate purchase behavior, wellness tracking and feedback loops. This approach will enable dynamic optimization of product portfolios and targeted marketing initiatives.

Investing in sustainable sourcing partnerships will not only enhance brand credibility but also ensure long-term supply chain resilience. Companies should explore vertical integration opportunities, from raw material cultivation to finished‐goods production, to safeguard against geopolitical and tariff-related disruptions.

To capture evolving consumer preferences, organizations must expand their digital footprint by collaborating with telehealth providers and wellness influencers, creating immersive experiences that build trust and foster community. Innovation pipelines should focus on multifunctional formulations that combine immune support with complementary benefits such as stress management and gut health.

Robust Methodological Framework Underpinning Market Analysis

The research underpinning this report integrated a dual approach combining primary engagements with industry stakeholders and comprehensive secondary data analysis. Interviews with formulators, supply chain experts and marketing executives provided firsthand perspectives on emerging challenges and opportunities.

Secondary sources encompassed regulatory filings, peer-reviewed journals and global trade databases, ensuring the inclusion of the latest trends in ingredient innovation and policy developments. Data triangulation methods were applied to reconcile discrepancies and validate findings, while segmentation frameworks were refined through iterative expert consultations.

Quality assurance protocols included cross-verification of proprietary market intelligence and scenario testing to assess supply chain resilience under various tariff structures. This rigorous methodology underlies the credibility and actionable value of all insights presented herein.

Synthesis of Key Findings Driving Market Evolution

In synthesizing the core insights, it is evident that the immunity booster supplement market is at a critical juncture defined by innovation, regulatory complexity and shifting consumer expectations. Segmentation analysis reveals multiple avenues for targeted growth, while regional disparities underscore the need for customized market entry strategies.

The impact of 2025 tariffs has catalyzed supply chain realignment, prompting a reappraisal of sourcing and pricing models. Competitive intelligence highlights the importance of strategic collaborations, digital engagement and sustainable practices as key differentiators. Together, these findings chart a course for stakeholders to navigate the evolving landscape with confidence and agility.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Form
    • Effervescent
    • Gummy
    • Liquid
    • Powder
    • Softgel
    • Tablet And Capsule
  • Ingredient Type
    • Herbal Extracts
    • Multivitamins
    • Probiotics
    • Vitamin C
    • Zinc
  • Distribution Channel
    • Direct Sales
    • E-Commerce
    • Pharmacy
    • Retail Stores
    • Specialty Stores
  • Product Type
    • Herbal
    • Natural
    • Synthetic
  • Gender
    • Female
    • Male
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • GNC Holdings, LLC
  • The Nature's Bounty Co.
  • NOW Health Group, Inc.
  • Glanbia plc
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Nature's Sunshine Products, Inc.
  • Swisse Wellness Pty Ltd

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunity Booster Supplement Market, by Form
8.1. Introduction
8.2. Effervescent
8.3. Gummy
8.4. Liquid
8.5. Powder
8.6. Softgel
8.7. Tablet and Capsule
9. Immunity Booster Supplement Market, by Ingredient Type
9.1. Introduction
9.2. Herbal Extracts
9.3. Multivitamins
9.4. Probiotics
9.5. Vitamin C
9.6. Zinc
10. Immunity Booster Supplement Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. E-Commerce
10.4. Pharmacy
10.5. Retail Stores
10.6. Specialty Stores
11. Immunity Booster Supplement Market, by Product Type
11.1. Introduction
11.2. Herbal
11.3. Natural
11.4. Synthetic
12. Immunity Booster Supplement Market, by Gender
12.1. Introduction
12.2. Female
12.3. Male
13. Americas Immunity Booster Supplement Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Immunity Booster Supplement Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Immunity Booster Supplement Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Herbalife Nutrition Ltd.
16.3.2. Amway Corp.
16.3.3. GNC Holdings, LLC
16.3.4. The Nature's Bounty Co.
16.3.5. NOW Health Group, Inc.
16.3.6. Glanbia plc
16.3.7. Bayer AG
16.3.8. Reckitt Benckiser Group plc
16.3.9. Nature's Sunshine Products, Inc.
16.3.10. Swisse Wellness Pty Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. IMMUNITY BOOSTER SUPPLEMENT MARKET MULTI-CURRENCY
FIGURE 2. IMMUNITY BOOSTER SUPPLEMENT MARKET MULTI-LANGUAGE
FIGURE 3. IMMUNITY BOOSTER SUPPLEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMMUNITY BOOSTER SUPPLEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMMUNITY BOOSTER SUPPLEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMMUNITY BOOSTER SUPPLEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY EFFERVESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GUMMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SOFTGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY TABLET AND CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY MULTIVITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ZINC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 75. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 80. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 81. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 90. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 95. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 105. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 110. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 115. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 120. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 121. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 125. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 130. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 145. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 150. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 160. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 161. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 165. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 186. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 188. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 191. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 211. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 241. IMMUNITY BOOSTER SUPPLEMENT MARKET SHARE, BY KEY PLAYER, 2024
TABLE 242. IMMUNITY BOOSTER SUPPLEMENT MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Immunity Booster Supplement market report include:
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • GNC Holdings, LLC
  • The Nature's Bounty Co.
  • NOW Health Group, Inc.
  • Glanbia plc
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Nature's Sunshine Products, Inc.
  • Swisse Wellness Pty Ltd

Methodology

Loading
LOADING...

Table Information